Abstract:This study addresses the relation between the exit of venture capital and opportunistic behavior in financial disclosure. Specifically, I examine whether the exit of venture capital is associated with income-increasing earnings management in the IPO year and financial statement restatements related to the period prior to the exit of venture capital. After controlling for the endogenous choice of exit, I document that, consistent with earnings management, the exit of venture capitalists (VCs) is significantly positively related to performance-matched discretionary accruals in the IPO year. Regardless of VCs' exiting, their stockholdings prior to the expiration of the lockup period are negatively related to discretionary accruals in the IPO year. Surprisingly, VC representation on the audit committee has no significant relation with income-increasing earnings management.Restatements are less likely to happen prior to or during the period of VCs' exit, and more likely to happen after VCs exiting. My results support this hypothesis. I find that the exit of venture capital right after the lockup expiration is negatively associated with the probability of announcing a restatement in the period T1, but positively associated with the probability of announcing a restatement in the period T2. More importantly, the exit of venture capital has a significant impact on the relation between VCs' stockholdings and the probability of announcing a restatement prior to VCs' exiting. Only for firms with VCs' exiting, does VC representation on the audit committee have a significantly negative association with the probability of announcing a restatement prior to VCs' exiting. Neither VCs' holdings nor VCs' representation on the audit committee has a significant relation with the probability of announcing a restatement after the exit of venture capital.The associations I find are robust to the usage of different instruments for the exit of venture capital, different measure for discretionary accruals, the inclusion of control variables for the intended use of proceeds, auditor's characteristics and CEO's incentives to manage earnings.Finally, my results indicate that as in the case without VC exit, firms with VCs exiting have similar abnormal stock returns during the lockup period and for the period from the lockup expiration through the record date of the first proxy available thereafter. The exit of venture capital is associated with a lower likelihood of securities class action after the IPO. In addition, I find some evidence that income-increasing earnings management imposes some costs on venture capitalists, e.g., fewer new IPOs and greater underpricing for new IPOs.Overall, my findings suggest that litigation risk and reputation cost are not strong enough to restrain venture capitalists from pursuing the benefits of opportunistic behavior in financial disclosure.

Share Structure and Entrepreneurship in UK Biotechnology Companies: An Empirical Study

Do Private Equity Investors Conspire with Ultimate Owners in the IPO Process?

Monitoring or Colluding: the Role of Venture Capital Investors in the IPO Process

Dual-Class Share Structures, Founder Control and Enterprise Growth:

Post-Ipo Governance: Venture Capitalists' Role in Real Options Exercise Decisions

Start-Up Investor Governance Case

Financing High-tech Start-ups: Moral Hazard, Information Asymmetry and the Reallocation of Control Rights

Venture capital activities under uncertainty: US and UK investors behavior

The winding journey of biotech capital raising: deciphering the jargon

THE EXIT OF VENTURE CAPITAL AND FINANCIAL DISCLOSURE IN NEWLY-PUBLIC FIRMS

VC ownership post‐IPO: When, why, and how do VCs exit?

Entrepreneurial Exits and Innovation

The Multi-BMBY Mechanism: Proportionality-Preserving and Strategyproof Ownership Restructuring in Private Companies

Insider Stock Pledges and Shareholder Wealth

Policies and structures for spinning off new companies from research and development organizations#

Startup Governance

Technology spillovers and capital gains in corporate venture capital investments: evidence from the biopharmaceutical industry

Equity in Startups

Dual Class Shares in the Age of Common Ownership

Inside the high-tech black box: A critique of technology entrepreneurship policy

Does Venture Capital Backing Improve Disclosure Controls and Procedures? Evidence from Management's Post-IPO Disclosures